OBJECTIVES: Obesity is an important risk factor for the development of insulin resistance and type 2 diabetes. Recently, a newly described circulating hormone resistin, which is expressed primarily in adipocytes, has been shown to antagonize insulin action in mice. Resistin, therefore, has been suggested to play a role in the pathogenesis of insulin resistance. RESEARCH METHODS AND PROCEDURES: We studied the expression of the resistin gene in primary cultured human adipocytes and preadipocytes. We also examined resistin gene expression in subcutaneous abdominal adipocytes in women (n = 24) over a wide range of body weight and insulin sensitivity. RESULTS: Whereas resistin gene expression was barely detectable in mature adipocytes, it was highly expressed in preadipocytes. Adipogenic differentiation of preadipocytes was associated with a time-dependent down-regulation of resistin gene expression. There was no relationship between body weight, insulin sensitivity, or other metabolic parameters and adipocyte resistin gene expression in the clinical study. DISCUSSION: Together these findings do not support an important role of adipose-tissue resistin gene expression in human insulin resistance.
OBJECTIVES: Obesity is an important risk factor for the development of insulin resistance and type 2 diabetes. Recently, a newly described circulating hormone resistin, which is expressed primarily in adipocytes, has been shown to antagonize insulin action in mice. Resistin, therefore, has been suggested to play a role in the pathogenesis of insulin resistance. RESEARCH METHODS AND PROCEDURES: We studied the expression of the resistin gene in primary cultured human adipocytes and preadipocytes. We also examined resistin gene expression in subcutaneous abdominal adipocytes in women (n = 24) over a wide range of body weight and insulin sensitivity. RESULTS: Whereas resistin gene expression was barely detectable in mature adipocytes, it was highly expressed in preadipocytes. Adipogenic differentiation of preadipocytes was associated with a time-dependent down-regulation of resistin gene expression. There was no relationship between body weight, insulin sensitivity, or other metabolic parameters and adipocyte resistin gene expression in the clinical study. DISCUSSION: Together these findings do not support an important role of adipose-tissue resistin gene expression in humaninsulin resistance.
Authors: P De Coppi; G Milan; A Scarda; L Boldrin; C Centobene; M Piccoli; M Pozzobon; C Pilon; C Pagano; P Gamba; R Vettor Journal: Diabetologia Date: 2006-06-24 Impact factor: 10.122
Authors: L Bouchard; S J Weisnagel; J C Engert; T J Hudson; C Bouchard; M C Vohl; L Pérusse Journal: J Endocrinol Invest Date: 2004-12 Impact factor: 4.256
Authors: Jessica L Fargnoli; Teresa T Fung; Deanna M Olenczuk; John P Chamberland; Frank B Hu; Christos S Mantzoros Journal: Am J Clin Nutr Date: 2008-11 Impact factor: 7.045
Authors: Mohammed Qatanani; Nava R Szwergold; David R Greaves; Rexford S Ahima; Mitchell A Lazar Journal: J Clin Invest Date: 2009-02-02 Impact factor: 14.808
Authors: A L Carey; E Wolsk Petersen; C R Bruce; R J Southgate; H Pilegaard; J A Hawley; B K Pedersen; M A Febbraio Journal: Diabetologia Date: 2006-03-15 Impact factor: 10.122